Skip to content
healthcare.dev

Docusate Sodium and Sennosides

NDC 35916-0453, Docusate Sodium and Sennosides, capsule, gelatin coated, from SOFTGEL HEALTHCARE PRIVATE LIMITED.

Product NDC
35916-0453
Status
Listed
Labeler
SOFTGEL HEALTHCARE PRIVATE LIMITED
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M007
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/35916-0453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SENNOSIDES8.6 mg/1
  • DOCUSATE SODIUM50 mg/1
Package NDCNDC-11Package
35916-0453-135916045301500 CAPSULE, GELATIN COATED in 1 BOTTLE (35916-0453-1)
35916-0453-3359160453032 POUCH in 1 BOX (35916-0453-3) / 3000 CAPSULE, GELATIN COATED in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 35916-0453 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/35916-0453 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 35916-0453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.